JP2004536842A - トログリタゾンおよびビグアナイドを含むコア製剤 - Google Patents

トログリタゾンおよびビグアナイドを含むコア製剤 Download PDF

Info

Publication number
JP2004536842A
JP2004536842A JP2003511800A JP2003511800A JP2004536842A JP 2004536842 A JP2004536842 A JP 2004536842A JP 2003511800 A JP2003511800 A JP 2003511800A JP 2003511800 A JP2003511800 A JP 2003511800A JP 2004536842 A JP2004536842 A JP 2004536842A
Authority
JP
Japan
Prior art keywords
acid
core
troglitazone
glucopyranosyl
metformin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003511800A
Other languages
English (en)
Japanese (ja)
Inventor
アジェイ，アクウィート，エル．
ヤピン ジュー，
キューティ，アンソニー，ジェイ．
Original Assignee
エアロファーム テクノロジー インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エアロファーム テクノロジー インコーポレイテッド filed Critical エアロファーム テクノロジー インコーポレイテッド
Priority claimed from PCT/US2001/021616 external-priority patent/WO2003005993A1/fr
Publication of JP2004536842A publication Critical patent/JP2004536842A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2003511800A 2001-07-10 2001-07-10 トログリタゾンおよびビグアナイドを含むコア製剤 Pending JP2004536842A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/021616 WO2003005993A1 (fr) 2000-05-01 2001-07-10 Formulation de noyau comprenant de la troglitazone et un biguanide

Publications (1)

Publication Number Publication Date
JP2004536842A true JP2004536842A (ja) 2004-12-09

Family

ID=32067644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003511800A Pending JP2004536842A (ja) 2001-07-10 2001-07-10 トログリタゾンおよびビグアナイドを含むコア製剤

Country Status (5)

Country Link
EP (1) EP1429740A4 (fr)
JP (1) JP2004536842A (fr)
AU (1) AU2001273290B2 (fr)
CA (1) CA2453782A1 (fr)
MX (1) MXPA04000181A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505903A (ja) * 2003-09-19 2007-03-15 アンドルックス ラボズ リミテッド ライアビリティ カンパニー ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416774B1 (en) * 1996-05-09 2002-07-09 The Trustees Of The University Of Pennsyvania Hollow bone mineral-like calcium phosphate particles
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
DE69939485D1 (de) * 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
DE19860699A1 (de) * 1998-12-30 2000-07-06 Hexal Ag Pharmazeutische Zusammensetzung
US6358531B1 (en) * 1999-02-01 2002-03-19 The Curators Of The University Of Missouri Method for preparing porous shells or gels from glass particles
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
WO2001035940A2 (fr) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Nouvelle composition et utilisation
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505903A (ja) * 2003-09-19 2007-03-15 アンドルックス ラボズ リミテッド ライアビリティ カンパニー ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤
JP4718465B2 (ja) * 2003-09-19 2011-07-06 アンドルックス ラボズ リミテッド ライアビリティ カンパニー ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤

Also Published As

Publication number Publication date
MXPA04000181A (es) 2004-11-22
EP1429740A1 (fr) 2004-06-23
EP1429740A4 (fr) 2005-01-26
AU2001273290B2 (en) 2004-10-07
CA2453782A1 (fr) 2003-01-23

Similar Documents

Publication Publication Date Title
US6524621B2 (en) Core formulation
US6451342B2 (en) Core formulation comprised of troglitazone and a biguanide
US6403121B1 (en) Core formulation
US6780432B1 (en) Core formulation
US6296874B1 (en) Core formulation comprising troglitazone and abiguanide
US20110301172A1 (en) Combination of dpp-iv inhibitor, ppar antidiabetic and metmorformin
BRPI0616694B1 (pt) Processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis
TW201206503A (en) Controlled release compositions with reduced food effect
JP2005516919A (ja) 抗糖尿病製剤および方法
US6461639B2 (en) Core formulation
JP2004536843A (ja) ピオグリタゾンおよびビグアナイドを含むコア製剤
WO2007007757A1 (fr) Composition pharmaceutique contenant un agoniste de ppar$g(g)
JP2004536841A (ja) コア製剤
AU2001273289A1 (en) Core formulation comprising pioglitazone hydrochloride and a biguanide
ES2290130T3 (es) Formulacion de nucleo.
AU2001273310A1 (en) A core formulation
JP2004536842A (ja) トログリタゾンおよびビグアナイドを含むコア製剤
AU2001257456A1 (en) A core formulation
AU2001273290A1 (en) Core formulation comprising troglitazone and a biguanide
TWI248815B (en) The controlled release formulation of metformin HCl
ES2366625T3 (es) Sistema de administración espaciada de fármacos.